Cargando…
MLL Rearrangements Impact Outcome in HOXA-deregulated T-lineage Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
Autores principales: | Matlawska-Wasowska, Ksenia, Kang, Huining, Devidas, Meenakshi, Wen, Ji, Harvey, Richard C., Nickl, Christian K., Ness, Scott A., Rusch, Michael, Li, Yongjin, Onozawa, Masahiro, Martinez, Carmen, Wood, Brent L., Asselin, Barbara L., Chen, I-Ming, Roberts, Kathryn G., Baruchel, André, Soulier, Jean, Dombret, Hervé, Zhang, Jinghui, Larson, Richard S., Raetz, Elizabeth A., Carroll, William L., Winick, Naomi J., Aplan, Peter D., Loh, Mignon L., Mullighan, Charles G., Hunger, Stephen P., Heerema, Nyla A., Carroll, Andrew J., Dunsmore, Kimberly P., Winter, Stuart S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014577/ https://www.ncbi.nlm.nih.gov/pubmed/26952838 http://dx.doi.org/10.1038/leu.2016.60 |
Ejemplares similares
-
Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL
por: Kang, Huining, et al.
Publicado: (2018) -
Epigenetic silencing of SOCS5 potentiates JAK‐STAT signaling and progression of T‐cell acute lymphoblastic leukemia
por: Sharma, Nitesh D., et al.
Publicado: (2019) -
Outstanding outcomes in infants with KMT2Agermline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial
por: Guest, Erin M., et al.
Publicado: (2022) -
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG
por: Burke, Michael J., et al.
Publicado: (2019) -
Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia
por: Yang, Wenjian, et al.
Publicado: (2022)